Home > News > Asensio Announces Investment Opinion on NVE
April 2nd, 2004
Asensio Announces Investment Opinion on NVE
Today Asensio & Company, Inc., with 12 years of experience as a leading independent equity research firm, published two research reports on NVE Corporation (NASDAQ Symbol: NVEC, $50.83) titled "NVEC fails to solve Cypress' MRAM problems" and "Cypress values NVEC at a maximum of $4.85 per share."
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014